ArticleIndian journal of microbiology2025
Production and Applications of Cyanobacterial Phycocyanin: Trends and Prospects.
Article in Indian journal of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Advances in natural colorants for functional confectionery; technological, sensory, and stability perspectives in chewing gum, hard candy, and toffee.Food chemistry: X · 2026Review
- Pre-mRNA splicing and its regulation in microalgae and cyanobacteria.Advanced biotechnology · 2025Review
- Investigation on the protective effects of the color stability of phycocyanin in vitro.Food chemistry: X · 2025Article
- Natural pigments derived from plants and microorganisms: classification, biosynthesis, and applications.Plant biotechnology journal · 2025Review
- Phycocyanin extraction fromCurrent research in food science · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
C-Phycocyanin (C-PC), is a natural blue pigment found mainly in cyanobacteria. Due to its extraordinary spectral properties and unique health benefits, this pigment has attracted significant attention in various industries. C-PC is widely studied and reported to have different pharmacological properties, notably antioxidant, anti-inflammatory, anti-cancer, neuroprotective, and hepatoprotective activities. Commercial exploitation of cyanobacterial phycocyanin relies on mass cultivation of selected cyanobacteria using different strategies like phototrophic, heterotrophic, mixotrophic, two-stage, open, and closed systems. Nonetheless, the production is influenced by different environmental factors especially light, pH and temperature as well as the availability of high yielding strains. Some of the bottlenecks like breaking the genetic barrier of sub-optimal yield or response to environmental factors can be addressed by genetic and metabolic engineering using advanced molecular tools. The present review discusses the production and application of C-PC along with possible molecular interventions to improve C-PC production. We have also discussed how strain improvement and diversified application can harness the commercial potential of C-PC in future to a greater extent.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.